SCHEMBL657195

SCHEMBL657195

CCOC(=O)C(C(=O)OCC)C(CC(=O)c1ccc2c(ccc3ccccc32)c1)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 4/20 0.49
ALDH1A1 P00352 3/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
KMT2A Q03164 2/20 0.45
NPC1 O15118 2/20 0.45
MEN1 O00255 1/20 0.45
GAA P10253 5/20 0.44
MGAM O43451 4/20 0.44
SI P14410 4/20 0.44
MGAM2 Q2M2H8 4/20 0.44
KDM4E B2RXH2 2/20 0.41
GLA P06280 1/20 0.41
APAF1 O14727 1/20 0.39
CDC25B P30305 1/20 0.39
CASP3 P42574 1/20 0.39
CASP6 P55212 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL656638 0.90 PDPK1 (0.53) PDPK1ALDH1A1MAPTHPGDKMT2A
SCHEMBL657993 0.85 PDPK1 (0.65) PDPK1ALDH1A1MAPTHPGDGAA
SCHEMBL657387 0.84 PDPK1 (0.58) PDPK1ALDH1A1MAPTHPGDKMT2A
SCHEMBL657072 0.84 ALDH1A1 (0.51) PDPK1ALDH1A1HPGDKMT2ANPC1
SCHEMBL7109210 0.81 KMT2A (0.67) PDPK1ALDH1A1MAPTHPGDKMT2A
SCHEMBL658879 0.78 KMT2A (0.55) PDPK1ALDH1A1MAPTHPGDKMT2A
SCHEMBL657882 0.78 NPC1 (0.55) PDPK1ALDH1A1MAPTHPGDKMT2A
SCHEMBL656693 0.78 KMT2A (0.55) PDPK1MAPTHPGDKMT2ANPC1
SCHEMBL657948 0.78 PDPK1 (0.50) PDPK1ALDH1A1MAPTHPGDKMT2A
SCHEMBL658260 0.77 KMT2A (0.52) PDPK1ALDH1A1MAPTHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349999-B1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIV SAARLAND (DE) 2016-01-27 EP disclosed
US-8912186-B2 Allosteric protein kinase modulators UNIVERSITAET DES SAARLANDES (DE) 2014-12-16 US disclosed
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2012-02-23 US disclosed
EP-2349999-A1 ALLOSTERIC PROTEIN KINASE MODULATORS Universität des Saarlandes (DE) 2011-08-03 EP disclosed
WO-2010043711-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2010-04-22 WO disclosed
EP-2177510-A1 Allosteric protein kinase modulators Universität des Saarlandes (DE) 2010-04-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS AURKC, AURKA, AURKB PDPK1 109/4885ALDH1A1 4784/4885MAPT 964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.